Stroke is a leading cause of morbidity and mortality worldwide. Early recognition and prompt management are key to improving outcomes and reducing disability. This article aims to provide healthcare professionals with a comprehensive guide to early stroke recognition and management.
Early recognition of stroke is pivotal to prompt treatment. The acronym FAST (Face drooping, Arm weakness, Speech difficulties, Time to call emergency services) is a widely accepted tool for stroke recognition. However, other subtle signs such as sudden confusion, trouble seeing, difficulty walking, or severe headache with no known cause should also raise suspicion.
Once a stroke is suspected, immediate medical attention is necessary. Intravenous thrombolysis with recombinant tissue plasminogen activator (rtPA) is the standard of care for ischemic strokes within 4.5 hours of symptom onset. Endovascular thrombectomy may be considered in certain patients with large vessel occlusion.
Neuroimaging plays a crucial role in differentiating ischemic from hemorrhagic stroke, which guides the treatment approach. Non-contrast CT scan is the initial imaging modality of choice due to its wide availability and speed. MRI may provide additional information in certain scenarios.
Once the acute phase is managed, focus shifts to secondary prevention to reduce the risk of recurrent stroke. This includes management of risk factors such as hypertension, diabetes, and hyperlipidemia, and initiation of antiplatelet therapy in ischemic stroke.
In conclusion, early recognition of stroke signs and prompt initiation of treatment can significantly improve patient outcomes. A holistic approach involving acute management, appropriate use of neuroimaging, and secondary prevention strategies is key to comprehensive stroke care. Continuous education and awareness among healthcare professionals about these aspects can greatly enhance stroke management.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation